// PL-001
Retatrutide
GIP / GLP-1 / Glucagon Triple Agonist
Select Size
COAAvailable
TestedBatch verified
DiscreetCareful shipping
Low Stock - 1 left
$75.99$59.99 USD / vial
₿ 5% Off With Crypto
Pay with BTC, ETH or USDT and save 5%
Research Effects
Retatrutide is a triple incretin receptor agonist acting on GIP, GLP-1, and glucagon receptors simultaneously.
- Up to 24% body weight reduction in Phase II trials
- Dual glucose-lowering via GLP-1 and GIP co-activation
- Liver fat reduction studied in MASH/NAFLD models
- Appetite suppression via central receptor pathways
- Increased energy expenditure via glucagon component